A Phase II Randomized Study Evaluating Azacitidine Versus Conventional Care Regimens in Newly Diagnosed Elderly Japanese Patients with Unfavorable Acute Myeloid Leukemia.
International Journal of Hematology（2022）
Key words
Azacitidine,Acute myeloid leukemia,Japanese patients,Phase 2 study,Front-line therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined